文献速递肾移植

移植前糖化血红蛋白较高与移植后糖尿病风险增加相关

Higher Pretransplantation Hemoglobin A1c Is Associated With Greater Risk of Posttransplant Diabetes Mellitus.
PubMed 文献 · Kidney Int Rep · 2017-06-22

该研究基于美国肾脏数据系统2005至2011年1499例无糖尿病原发肾移植受者,分析移植前HbA1c与移植后糖尿病(PTDM)的关联。中位随访1.8年,26.4%发生PTDM;移植前HbA1c低于5.4%时无显著关联,而高于5.4%后每升高1%,PTDM风险调整后风险比为1.84(95%CI 1.28-2.66;斜率变化P=0.04)。

要点

  • 移植前HbA1c>5.4%者PTDM风险随HbA1c升高而增加。
  • HbA1c低于5.4%时未见PTDM风险显著增加。
  • 风险升高始于低于糖尿病前期诊断阈值的HbA1c水平。

核心结论

  • 移植前HbA1c高于5.4%与肾移植受者PTDM风险独立相关,且风险从远低于糖尿病前期阈值的水平开始增加。

研究设计与样本

  • 回顾性队列分析美国肾脏数据系统2005至2011年1499例无糖尿病原发肾移植受者,均有移植前HbA1c值。
  • 排除移植前已诊断糖尿病或HbA1c≥6.5%者,采用Cox比例风险模型评估关联。

主要发现

  • 中位随访1.8年,395例(26.4%)发生PTDM。
  • 移植前HbA1c低于5.4%时与PTDM风险无显著关联。
  • 移植前HbA1c高于5.4%后每升高1%,PTDM调整后风险比为1.84(95%CI 1.28-2.66;斜率变化P=0.04)。

临床怎么用

  • 对移植前HbA1c高于5.4%的受者应加强PTDM监测与预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Posttransplantation diabetes mellitus (PTDM) is a common complication among kidney transplant recipients and is associated with a higher risk of cardiovascular events and poorer graft and patient survival. The association of pretransplantation hemoglobin A1c (HbA1c) with PTDM remains unclear. Identifying recipients at greatest risk for PTDM may help guide monitoring and treatment strategies to prevent or delay the onset of PTDM. METHODS: We analyzed data from 1499 nondiabetic primary kidney transplant recipients with available pretransplantation HbA1c values in the United States Renal Data System (USRDS) from 2005 to 2011. Recipients with pretransplantation diabetes diagnosis or HbA1c ≥ 6.5% were excluded. We assessed the association of pretransplantation HbA1c with PTDM using Cox proportional hazards models. Pretransplantation HbA1c level as a continuous variable was modeled using restricted cubic splines with knots at the 25th, 50th, and 75th percentiles. Based on results from this model, pretransplantation HbA1c was further modeled using a linear spline with a single knot at 5.4%. RESULTS: A total of 395 recipients (26.4%) developed PTDM over a median follow-up of 1.8 years. Pretransplantation HbA1c was not significantly associated with risk of PTDM below 5.4%, whereas each 1% higher HbA1c above 5.4% was associated with an adjusted hazard ratio of 1.84 (95% confidence interval = 1.28, 2.66; P for change in slope = 0.04). DISCUSSION: Higher pretransplantation HbA1c above 5.4% is independently associated with greater risk of PTDM among kidney transplant recipients. A continuous relationship between pretransplantation HbA1c and risk of PTDM suggests that increased risk starts at HbA1c levels well below current thresholds for prediabetes.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Shin JI, Palta M, Djamali A, et al. Higher Pretransplantation Hemoglobin A1c Is Associated With Greater Risk of Posttransplant Diabetes Mellitus. Kidney Int Rep. 2017. PMID: 29270516. doi:10.1016/j.ekir.2017.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。